Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer

Area of Science:

• Oncology
• Endocrinology
• Cancer Biology

Background:

• Non-small cell lung cancer (NSCLC) recurrence rates differ between diabetic and non-diabetic patients.
• Epithelial-to-mesenchymal transition (EMT) is crucial for tumor recurrence and metastasis.
• Understanding diabetes' impact on NSCLC tumor microenvironment is vital.

Purpose of the Study:

• To investigate differences in EMT marker expression in NSCLC between diabetic and non-diabetic patients.
• To explore the potential link between diabetes and enhanced tumor invasiveness in NSCLC.

Main Methods:

• Analysis of 79 NSCLC patients from a multicenter study cohort.
• Classification into adenocarcinoma and squamous cell carcinoma groups, with and without diabetes.
• Immunohistochemical analysis of eight EMT markers: TGF-β, EGFR, IGF-1R, vimentin, E-cadherin, N-cadherin, HtrA1, and beta-catenin.

Main Results:

• Significantly higher expression of E-cadherin, HtrA1, TGF-β, IGF-1R, and vimentin in diabetic NSCLC patients.
• Increased N-cadherin expression in diabetics, though not statistically significant.
• EGFR showed higher expression in diabetic squamous cell carcinoma, while beta-catenin showed no difference.

Conclusions:

• Diabetes is associated with enhanced EMT in NSCLC.
• These findings suggest diabetes may promote NSCLC growth and invasiveness through altered tumor biology.